低氧誘導(dǎo)因子2α(HIF2a)重組蛋白
Recombinant Hypoxia Inducible Factor 2 Alpha (HIF2a)
EPAS1; HLF; MOP2; PASD2; BHLHE73; Endothelial PAS Domain 1; HIF-1 Alpha-Like Factor; Basic-helix-loop-helix-PAS protein MOP2; Class E basic helix-loop-helix protein 73
- 編號URPD466Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量23.6kDa
- 實際分子量27kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Cys339~Gln541 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點4.4
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 523 ¥ 1308 ¥ 2616 ¥ 7848 ¥ 19620
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPD466Hu02 | 低氧誘導(dǎo)因子2α(HIF2a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPD466Hu01 | 低氧誘導(dǎo)因子2α(HIF2a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAD466Hu02 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體 | IHC |
| UPAD466Hu01 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體 | WB; IHC |
| ULAD466Hu71 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAD466Hu21 | 低氧誘導(dǎo)因子2α(HIF2a)單克隆抗體 | WB; IHC; ICC; IP. |
| USED466Hu | 低氧誘導(dǎo)因子2α(HIF2a)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMD466Hu | 低氧誘導(dǎo)因子2α(HIF2a)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSD466Hu01 | 低氧誘導(dǎo)因子2α(HIF2a)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Neuro Oncol | Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling [PubMed: 26409567] |
| Clinical Trials in Degenerative Diseases | Correlating oxidative stress-related factors with bone metabolic markers in older adult male patients exhibiting degenerative osteoporosis in the high-altitude hypoxic area of China: study protocol for a non-randomized controlled trial [issn:2542-3975] |
| Journal of Physiological Anthropology | Telomere elongation protects heart and lung tissue cells from fatal damage in rats exposed to severe hypoxia [Pubmed:29454386] |
| Oxidative damage and iron dyshomeostasis in thalassemic patients [] | |
| Neuropsychiatric Disease and Treatment | The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder [34588778] |
留言咨詢
